Abstract | OBJECTIVE: DESIGN: Survey of a random sample of 250 California cardiologists between July 1989 and February 1990. RESULTS: CONCLUSIONS: These results indicate that physicians place great emphasis on surrogate end points. Physicians vary in their willingness to use more expensive therapies over cheaper alternatives, even when their perceptions of the relative risks and benefits are similar. The patient's insurance status and the provider's practice setting may exert an important influence on doctors' clinical choices.
|
Authors | D S Lessler, A L Avins |
Journal | Archives of internal medicine
(Arch Intern Med)
Vol. 152
Issue 8
Pg. 1665-72
(Aug 1992)
ISSN: 0003-9926 [Print] United States |
PMID | 1497400
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Streptokinase
- Tissue Plasminogen Activator
|
Topics |
- California
(epidemiology)
- Chi-Square Distribution
- Confidence Intervals
- Costs and Cost Analysis
(statistics & numerical data)
- Drug Prescriptions
(economics, statistics & numerical data)
- Humans
- Logistic Models
- Myocardial Infarction
(drug therapy, economics, epidemiology)
- Prognosis
- Risk Assessment
- Streptokinase
(adverse effects, therapeutic use)
- Surveys and Questionnaires
- Thrombolytic Therapy
(adverse effects, economics, statistics & numerical data)
- Tissue Plasminogen Activator
(adverse effects, therapeutic use)
- Uncertainty
|